New Target for Antiviral Herpes Therapies

Key Mechanism of Herpesvirus Egress Uncovered Hamburg, June 27, 2024. An international team of researchers, led by the Leibniz Institute of Virology (LIV), uncovered crucial details on how herpesviruses exit the cell nucleus without compromising the integrity of the nuclear envelope. The study, published on June 25 in the renowned journal Nature Microbiology, utilized advanced electron cryo-tomography to visualize the structures involved. These findings could pave the way for developing more effective antiviral therapies to combat herpesvirus infections.

Background Research:

Herpesviruses are a family of viruses that cause some of the most prevalent and stubborn lifelong infections in humans. Commonly known are Herpes Simplex Virus (HSV), causing cold sores, and varicella-zoster virus, causing chickenpox. The herpesvirus hides itself inside the host’s cells,surrounded by a protein shell called capsid.

The process by which these viruses exit or egress from the nucleus of host cells, while maintaining the integrity of nuclear membrane has long remained an enigma in microbiology. The Leibniz Institute for Experimental Virology (LIV) is known for its pioneering work in virology and has pushed boundaries to understand this unnoticed detail of herpesvirus egress using advanced techniques like electron cryo-tomography.

Electron Cryo-Tomography (ECT) is an advanced imaging technology that allows scientists to view frozen-hydrated specimens at a resolution finer than anything previous methods could allow. It helps visualize individual macromolecules within their preserved cellular environment enhancing our understanding about how these microscopic organisms work.

FAQs:

1. What was the aim of this research?
– The study aimed to uncover details about how herpesviruses leave or exit from nucleus (center part) of host cells without damaging it.

2. Who led this research?
– An international team led by researchers from Leibniz Institute for Experimental Virology conducted the new study.

3. Where was the study published?
– It was published in Nature Microbiology, which is considered one renowned journal in field.

4. How did they accomplish this research?
– They used Electron Cryo-Tomography imaging technique that allowed them to see these microscopic events happening within cellular envelope preserving its original state.

5. What does this discovery mean?
– This unveiling can pave way towards creating better antiviral therapies as now we know more about how these viruses leave cells after replication. By disturbing their identified escape path, one can craft strategies to contain viral spread.

6. Does this research indicate cure for Herpes?
– While it does not signify a direct cure, understanding the egress mechanism of herpesviruses could lead to the development of antiviral drugs that can disrupt this process and prevent multiplication and spread of virus.

7. What is Electron Cryo-tomography (ECT)?
– Electron Cryo-Tomography is an advanced imaging technology which allows scientists to visualize frozen-hydrated specimens at very fine resolution enabling them to see individual macromolecules within their preserved cellular environment.

8. Who will benefit from these findings?
– These findings are most beneficial to scientists and researchers all over world who are working on creating antiviral therapies against all types of herpesvirus infections.

Originamitteilung:

Key Mechanism of Herpesvirus Egress Uncovered

Hamburg, June 27, 2024. An international team of researchers, led by the Leibniz Institute of Virology (LIV), uncovered crucial details on how herpesviruses exit the cell nucleus without compromising the integrity of the nuclear envelope. The study, published on June 25 in the renowned journal Nature Microbiology, utilized advanced electron cryo-tomography to visualize the structures involved. These findings could pave the way for developing more effective antiviral therapies to combat herpesvirus infections.

share this recipe:
Facebook
Twitter
Pinterest

Weitere spannende Artikel

Bioreactor Allows Automated Long-Term Culturing of Stem Cells

Human induced pluripotent stem cells (hiPSCs) are considered as a promising tool in medicine, with the potential to unlock treatments for many health conditions such as neurodegenerative diseases and disorders. However, producing large amounts of hiPSCs remains a challenge. Researchers from the Fraunhofer Translational Center for Regenerative Therapies TLC-RT at the Fraunhofer Institute for Silicate Research ISC have now developed a bioreactor that can be used for automated long-term culturing of hiPSCs.

Read More

Bioreaktor ermöglicht automatisierte Langzeitkultivierung von Stammzellen

Humane induzierte pluripotente Stammzellen (hiPSCs) gelten als vielversprechendes Werkzeug in der Medizin: Künftig sollen sie die Therapie von vielen Leiden wie etwa neurodegenerativen Erkrankungen ermöglichen. Nach wie vor ist jedoch die Herstellung großer Mengen an hiPSCs eine Herausforderung. Forschende des Fraunhofer-Translationszentrums für Regenerative Therapien TLZ-RT am Fraunhofer-Institut für Silicatforschung ISC haben nun einen Bioreaktor entwickelt, mit dem eine automatisierte Langzeitkultivierung von hiPSCs gelingt.

Read More